2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Dyspnea: new trials by email Literature Review of Dyspnea trials Research Report on Dyspnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD Placebo, Treprostinil Inhalation Solution 36 mcg, Treprostinil Inhalation Solution 78 mcg - COPD (Chronic Obstructive Pulmonary Disease) | Phase 2 | Active not recruiting | University of Alberta | 20 | 2025-06-05 | 2026-11-05 |
| Dexamethasone in Controlling Dyspnea in Patients With Cancer Dexamethasone, Placebo, Questionnaire Administration - Dyspnea, Malignant Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 135 | 2017-12-04 | 2026-10-16 |
Neoplasms (1) · Pulmonary Disease, Chronic Obstructive (1)
Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Chronic Disease (1) · Disease Attributes (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathologic Processes (1)
Calcium Dobesilate (1) · Dexamethasone (1) · auricularum (1) · dexamethasone 21-phosphate (1) · dexamethasone acetate (1)
M.D. Anderson Cancer Center (1) · University of Alberta (1)
Canada (1) · United States (1)
David Hui (1) · Michael Stickland (1)